The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population

Abstract

Overall five-year and ten-year survival (all-cause) has improved even when compared with UK data for BC-specific survival. We found that the NPI remains valid for BC treatment, and that our data provide a reference for updating the all-cause survival of women diagnosed with BCs within a screened population.